David Moatazedi files SEC Form 4 disclosures for Evolus, Inc.. They have made 14 open-market trades across 2 companies since 2021, most recently 2026-09-02.
CIK 0001700836
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $16K since 2026, against 13 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| EOLS | 499,592 | $3.5M |
| OBLN | 83,619 | $765K |
| BMRA | 40,625 | $74K |
| Total | $4.4M |
Shares reported on the most recent Form 4, priced at the 2026-09-04 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| EOLS | SELL | 2026-09-02 | 2026-09-04 | $9.04 | $950K | -10.1% | -15.9% | — |
| BMRA | BUY | 2026-08-26 | 2026-08-27 | $1.60 | $16K | +7.7% | +8.7% | — |
| EOLS | SELL · 10b5-1 | 2026-03-20 | 2026-03-20 | $4.75 | $130K | -7.3% | +9.6% | +42.3% |
| EOLS | SELL · 10b5-1 | 2026-03-17 | 2026-03-18 | $4.89 | $1.1M | -17.1% | -1.3% | +40.0% |
| EOLS | SELL · 10b5-1 | 2025-12-22 | 2025-12-29 | $7.15 | $151K | -14.7% | -27.5% | -40.5% |
| EOLS | SELL | 2025-06-13 | 2025-06-16 | $10.03 | $2.6M | -7.5% | -6.9% | -32.9% |
| EOLS | SELL · 10b5-1 | 2025-05-12 | 2025-05-14 | $9.87 | $312K | -1.6% | -0.4% | -35.8% |
| EOLS | SELL · 10b5-1 | 2025-03-27 | 2025-03-28 | $12.40 | $155K | -11.4% | -3.3% | -20.4% |
| EOLS | SELL · 10b5-1 | 2025-03-18 | 2025-03-20 | $13.26 | $2.7M | -8.8% | -21.1% | -29.3% |
| EOLS | SELL · 10b5-1 | 2024-12-23 | 2024-12-26 | $10.85 | $228K | -9.2% | +31.2% | +10.5% |
| EOLS | SELL | 2024-06-04 | 2024-06-06 | $12.74 | $12.0M | -13.1% | -9.4% | +25.8% |
| EOLS | SELL | 2024-05-10 | 2024-05-14 | $12.72 | $408K | -2.6% | -9.8% | +1.6% |
| EOLS | SELL | 2024-03-27 | 2024-03-29 | $13.86 | $173K | -8.8% | -16.4% | -21.9% |
| EOLS | SELL | 2024-03-19 | 2024-03-21 | $13.92 | $2.7M | -1.5% | -15.0% | -21.9% |
| EOLS | SELL · 10b5-1 | 2024-02-22 | 2024-02-23 | $13.08 | $202K | +3.0% | +0.7% | -9.1% |
| EOLS | SELL | 2023-12-06 | 2023-12-08 | $10.01 | $1.3M | +0.0% | +7.1% | +52.8% |
| EOLS | SELL · 10b5-1 | 2023-08-16 | 2023-08-16 | $10.27 | $304K | -2.9% | -7.4% | -17.1% |
| EOLS | SELL · 10b5-1 | 2023-03-27 | 2023-03-29 | $8.47 | $104K | -1.7% | +4.2% | -13.1% |
| EOLS | SELL | 2023-03-14 | 2023-03-16 | $8.47 | $1.1M | -3.0% | -4.6% | -8.5% |
| EOLS | SELL | 2022-05-16 | 2022-05-18 | $13.64 | $1.5M | +6.2% | -4.9% | -19.3% |
| EOLS | SELL | 2022-03-28 | 2022-03-30 | $11.62 | $142K | +1.8% | +1.5% | +7.6% |
| EOLS | SELL | 2022-03-08 | 2022-03-10 | $9.73 | $739K | +13.9% | +8.6% | +21.4% |
| EOLS | SELL | 2021-08-13 | 2021-08-17 | $11.13 | $1.6M | +4.1% | -21.5% | -31.1% |
| EOLS | SELL · 10b5-1 | 2021-08-10 | 2021-08-12 | $11.18 | $934K | +3.0% | -24.9% | -30.7% |
| EOLS | SELL | 2021-01-25 | 2021-01-26 | $7.46 | $124K | +9.7% | +80.5% | +46.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.